- NEGATIVE
Quarterly Revenue Quest Laboratories Mar-2026 Quarterly Revenue is Rs 31 Cr which is growth of -37.3% YoY.
- NEGATIVE
Quarterly Net Profit Quest Laboratories Mar-2026 Quarterly Net Profit is Rs 3 Cr which is growth of -40.0% YoY.
Quest Laboratories quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Quest Laboratories quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Dec '23 |
|---|---|---|---|---|---|---|---|---|
| 31.1 | 31.2 | 27 | 25 | 49.6 | 15.1 | 21.1 | ||
Operating Exp. | 28.3 | 23.7 | 22.2 | 19.4 | 42.5 | 14.2 | 18.4 | |
Operating Profit | 4.1 | 6.9 | 3.4 | 3.8 | 4 | 0.7 | 2.7 | |
Operating Profit Margin % | 12.76% | 22.57% | 13.22% | 16.44% | 8.51% | 4.48% | 12.81% | |
Depr. | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | |
Interest | 0.2 | 0.5 | 0.6 | 0.6 | 0.4 | 0 | 0.3 | |
Profit Before Tax | 2.5 | 6.8 | 4 | 4.8 | 6.5 | 0.8 | 2.3 | |
Tax | -0.4 | 2.8 | 0.7 | 1.7 | 0.9 | |||
Net Profit | 2.9 | 4 | 4 | 4.1 | 4.8 | 0.8 | 1.4 | |
EPS Adj. latest | 1.8 | 2.5 | 2.5 | 2.5 | 2.9 | 0.5 | 0.9 | |
Net profit TTM | 15 | 16.9 | 13.7 | - | - | - | - | |
Basic EPS TTM | 9.2 | 8.3 | 8.3 | 8.3 | 8.3 | 6.2 | 4.7 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Quest Laboratories competitor comparison and performance snapshot within industry
Quest Laboratories annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Annual Revenue Quest Laboratories Mar-2026 Annual Revenue is Rs 114 Cr which is growth of 5.7% YoY.
- POSITIVE
Annual Net Profit Quest Laboratories Mar-2026 Annual Net Profit is Rs 15 Cr which is growth of 10.7% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | TTM | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 |
|---|---|---|---|---|---|---|---|---|---|---|
22.7% | 30.3% | 114.4 | 114.4 | 108.2 | 82.8 | 61.9 | 59.5 | 30.4 | ||
Operating Exp. Ann. | 20.3% | 26.4% | 93.6 | 93.6 | 88 | 67 | 53.8 | 53 | 29 | |
Operating Profit Ann. | 32.6% | 67% | 18.2 | 18.2 | 16 | 15.6 | 7.8 | 6.5 | 1.4 | |
OPM Ann. % | 8.1% | 27.9% | 15.95% | 14.77% | 18.78% | 12.64% | 10.86% | 4.66% | ||
20.6% | 26.5% | 96.3 | 89.5 | 68.4 | 54.9 | 53.8 | 29.7 | |||
EBITDA Ann. | 36.9% | 69.2% | 20.8 | 20.2 | 15.8 | 8.1 | 6.5 | 1.5 | ||
EBITDA Ann. margin % | 11.8% | 30% | 18.17% | 18.69% | 19.06% | 13.01% | 10.96% | 4.90% | ||
Interest Ann. | 56% | 44.7% | 1.9 | 1.9 | 0.9 | 0.8 | 0.5 | 0.3 | 0.3 | |
Depr. | 10.1% | 14.9% | 0.8 | 0.8 | 0.6 | 0.6 | 0.6 | 0.5 | 0.4 | |
PBT Ann. | 37.3% | 86.6% | 18.1 | 18.1 | 18.7 | 14.5 | 7 | 5.8 | 0.8 | |
Tax Ann. | 17.7% | 98.7% | 3.1 | 3.1 | 5.1 | 4.4 | 1.9 | 1.7 | 0.1 | |
44.2% | 84.6% | 15 | 13.6 | 10.1 | 5 | 4.1 | 0.7 | |||
Net Profit Ann. | 44.2% | 84.6% | 15 | 15 | 13.6 | 10.1 | 5 | 4.1 | 0.7 | |
NPM Ann. % | 18.1% | 44.2% | 13.42% | 13.04% | 12.22% | 8.15% | 6.90% | 2.15% | ||
EPS Adj. latest Ann. | 43.7% | 87.2% | 9.2 | 8.3 | 6.2 | 3.1 | 2.5 | 0.4 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
5.7%
2Y CAGR
17.5%
3Y CAGR
22.7%
5Y CAGR
30.3%
Total Revenue Annual growth is lower than historical averages.
Net Profit Ann.
1Y CHG
10.3%
2Y CAGR
21.9%
3Y CAGR
44.2%
5Y CAGR
84.6%
Net Profit Annual growth is lower than historical averages.
Operating Exp. Ann.
1Y CHG
6.4%
2Y CAGR
18.2%
3Y CAGR
20.3%
5Y CAGR
26.4%
Operating Expenses Annual Cr growth is lower than historical averages.
Quest Laboratories balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Quest Laboratories Mar-2025 Total Shareholders Fund is Rs 97 Cr which is growth of 18.4% YoY.
- NEGATIVE
Total Assets Quest Laboratories Mar-2025 Total Assets is Rs 111 Cr which is growth of -8.6% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 |
|---|---|---|---|---|---|---|---|---|---|
86.2% | 75% | 96.8 | 81.8 | 28.6 | 15 | 10 | 5.9 | ||
Minority Interest Liability Ann. | - | - | - | - | - | - | - | - | |
-13.7% | 2.4% | 1.8 | 2.7 | 2 | 2.8 | 1.9 | 1.6 | ||
-24.3% | 2.6% | 12.5 | 37.2 | 28.7 | 28.8 | 22.9 | 11 | ||
Total Capital Plus Liabilities Ann. | 33.5% | 43.3% | 111.2 | 121.7 | 59.3 | 46.7 | 34.8 | 18.4 | |
26% | 27.1% | 19.6 | 11.8 | 10.2 | 9.8 | 7.4 | 5.9 | ||
22.7% | 25.5% | 19.6 | 14.7 | 17.7 | 10.6 | 8 | 6.3 | ||
36.3% | 49.9% | 91.5 | 107 | 41.6 | 36.1 | 26.8 | 12.1 | ||
Total Assets Ann. | 33.5% | 43.3% | 111.2 | 121.7 | 59.3 | 46.7 | 34.8 | 18.4 | |
Contingent Liabilities plus Commitments Ann. | - | - | - | 0.9 | 6.8 | 2.8 | 2.8 | ||
Bonus Equity Share Capital Ann. | - | - | - | ||||||
Non Current Investments Unquoted Book Value Ann. | - | - | - | ||||||
Current Investments Unquoted Book Value Ann. | - | - | - | 47.5 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-8.6%
2Y CAGR
36.9%
3Y CAGR
33.5%
5Y CAGR
43.3%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
-66.4%
2Y CAGR
-34%
3Y CAGR
-24.3%
5Y CAGR
2.6%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
18.3%
2Y CAGR
84%
3Y CAGR
86.2%
5Y CAGR
75%
Total ShareHolders Funds Annual growth is lower than historical averages.
Quest Laboratories ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Book Value Per Share Quest Laboratories Mar-2025 Book Value Per Share is 59 Rs which is growth of 18.4% YoY.
- POSITIVE
ROE Quest Laboratories Mar-2025 ROE is 16% which is growth of 1.1% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 |
|---|---|---|---|---|---|---|---|---|---|
BVSH Ann. | -24.9% | 1.6% | 59.1 | 49.9 | 24 | 139.3 | 92.6 | 54.6 | |
RoA Ann. % | 7.8% | 30.6% | 13.51% | 11.15% | 17.02% | 10.77% | 11.79% | 3.56% | |
ROE Ann. % | -22.6% | 6.9% | 15.51% | 16.58% | 35.23% | 33.47% | 41.07% | 11.12% | |
ROCE Ann. % | -21.6% | 6.6% | 20.23% | 23.19% | 49.64% | 42.04% | 51.14% | 14.73% | |
Total Debt to Total Equity Ann. | -30.7% | -27.5% | 0.1 | 0.4 | 0.2 | 0.3 | 0.3 | 0.5 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
ROE Ann. %
1Y CHG
-6.5%
2Y CAGR
-33.6%
3Y CAGR
-22.6%
5Y CAGR
6.9%
ROE Annual % is falling faster than historical averages.
RoA Ann. %
1Y CHG
21.2%
2Y CAGR
-10.9%
3Y CAGR
7.8%
5Y CAGR
30.6%
RoA Annual % is stable compared to historical averages.
Current Ratio Ann.
1Y CHG
151.7%
2Y CAGR
120.6%
3Y CAGR
77.7%
5Y CAGR
46%
Current Ratio Annual growth is higher than historical averages.
Quest Laboratories cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Cash From Operating Activity Quest Laboratories Mar-2026 Cash From Operating Activity is Rs -11 Cr which is growth of 54.4% YoY.
- POSITIVE
Net Cash Flow Quest Laboratories Mar-2026 Net Cash Flow is Rs -0 Cr which is growth of 82.4% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 |
|---|---|---|---|---|---|---|---|---|---|
- | - | -10.7 | -23.5 | 3 | 3.6 | 3.5 | 1.1 | ||
Cash from Investing Act. Ann. | - | - | 34.9 | -44 | -5 | -3 | -1.9 | -1.2 | |
Cash from Financing Act. Ann. | - | - | -24.2 | 67.4 | 2 | 0.3 | -0.4 | 0 | |
- | - | -0 | -0 | 0 | 0.9 | 1.2 | -0.1 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
